Fig 3.

(A) T-lymphocyte cell counts in peripheral blood were markedly reduced after receiving 3.0 mg/kg rATG, an effect maintained in the absence of maintenance immunosuppression for > 5 months until a second attempt at islet transplantation was successful under basiliximab and etanercept induction, and then for another year under tacrolimus and sirolimus maintenance. (B) All T-lymphocyte cell subsets were similarly reduced following rATG.